openPR Logo
Press release

Restless Leg Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Synthonics Inc., American Regent, Inc., GlaxoSmithKline, Astellas Pharma Inc., UCB Pharma, XenoPort Inc., Neurocare

03-20-2025 08:38 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Restless Leg Syndrome Market

Restless Leg Syndrome Market

DelveInsight's "Restless Leg Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Restless Leg Syndrome, historical and forecasted epidemiology as well as the Restless Leg Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Discover which therapies are expected to grab the Restless Leg Syndrome Market Share @ Restless Leg Syndrome Market Outlook- https://www.delveinsight.com/sample-request/restless-leg-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Restless Leg Syndrome Market Report
• In December 2024, Astellas Pharma Inc. announced a study was to assess the efficacy of once-daily oral administration of gabapentin enacarbil versus placebo, based on the change in International Restless Legs Syndrome Rating Scale (IRLS) score in participants with moderate-to-severe idiopathic restless legs syndrome. This study also assessed the safety of Gabapentin enacarbil.
• The increase in Restless Leg Syndrome Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Restless Leg Syndrome Market is anticipated to witness growth at a considerable CAGR.
• The leading Restless Leg Syndrome Companies such as Synthonics Inc., American Regent, Inc., GlaxoSmithKline, Astellas Pharma Inc., UCB Pharma, XenoPort Inc., Neurocare, and others.
• Promising Restless Leg Syndrome Pipeline Therapies such as IncobotulinumtoxinA, Chylobinoid Topical Cream, Ferric Carboxymaltose, Ropinirole, ASP8825, Rotigotine, GSK1838262 Extended Release Tablets, Pregabalin and others.

Stay ahead in the Restless Leg Syndrome Therapeutics Market with DelveInsight's Strategic Report @ Restless Leg Syndrome Market Outlook- https://www.delveinsight.com/sample-request/restless-leg-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Restless Leg Syndrome Epidemiology Segmentation in the 7MM
The epidemiology section of Restless Leg Syndrome offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

Download the report to understand which factors are driving Restless Leg Syndrome Epidemiology trends @ Restless Leg Syndrome Prevalence- https://www.delveinsight.com/sample-request/restless-leg-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Restless Leg Syndrome Drugs Market
The Restless Leg Syndrome Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Restless Leg Syndrome signaling in Restless Leg Syndrome are likely to uncover new therapeutic targets and further expand treatment options for patients.

Restless Leg Syndrome Treatment Market Landscape
The Restless Leg Syndrome treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Restless Leg Syndrome has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To learn more about Restless Leg Syndrome treatment guidelines, visit @ Restless Leg Syndrome Treatment Market Landscape- https://www.delveinsight.com/sample-request/restless-leg-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Restless Leg Syndrome Market Outlook
The report's outlook on the Restless Leg Syndrome market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Restless Leg Syndrome therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Restless Leg Syndrome drug and late-stage pipeline therapy.

Restless Leg Syndrome Drugs Uptake
The drug chapter of the Restless Leg Syndrome report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Restless Leg Syndrome.

Major Restless Leg Syndrome Companies
Synthonics Inc., American Regent, Inc., GlaxoSmithKline, Astellas Pharma Inc., UCB Pharma, XenoPort Inc., Neurocare, and others

Learn more about the FDA-approved drugs for Restless Leg Syndrome @ Drugs for Restless Leg Syndrome Treatment- https://www.delveinsight.com/sample-request/restless-leg-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Restless Leg Syndrome Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Restless Leg Syndrome Companies- Synthonics Inc., American Regent, Inc., GlaxoSmithKline, Astellas Pharma Inc., UCB Pharma, XenoPort Inc., Neurocare, and others
• Restless Leg Syndrome Pipeline Therapies- IncobotulinumtoxinA, Chylobinoid Topical Cream, Ferric Carboxymaltose, Ropinirole, ASP8825, Rotigotine, GSK1838262 Extended Release Tablets, Pregabalin and others.
• Restless Leg Syndrome Market Dynamics: Restless Leg Syndrome Market Drivers and Barriers
• Restless Leg Syndrome Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about Restless Leg Syndrome Drugs in development @ Restless Leg Syndrome Clinical Trials Assessment- https://www.delveinsight.com/sample-request/restless-leg-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Restless Leg Syndrome Executive Summary
3. Competitive Intelligence Analysis for Restless Leg Syndrome
4. Restless Leg Syndrome: Market Overview at a Glance
5. Restless Leg Syndrome: Disease Background and Overview
6. Patient Journey
7. Restless Leg Syndrome Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Restless Leg Syndrome Unmet Needs
10. Key Endpoints of Restless Leg Syndrome Treatment
11. Restless Leg Syndrome Marketed Products
12. Restless Leg Syndrome Emerging Therapies
13. Restless Leg Syndrome: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Restless Leg Syndrome Market Outlook
16. Access and Reimbursement Overview of Restless Leg Syndrome
17. KOL Views
18. Restless Leg Syndrome Market Drivers
19. Restless Leg Syndrome Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Restless Leg Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Synthonics Inc., American Regent, Inc., GlaxoSmithKline, Astellas Pharma Inc., UCB Pharma, XenoPort Inc., Neurocare here

News-ID: 3926178 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Restless

Restless Legs Syndrome - Drug Pipeline Landscape, 2022
Restless Legs Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move one's legs. The exact cause of RLS is unknown, but it is thought to be associated with a dysfunction in the brain's dopamine system. This system is responsible for regulating movement and is also involved in the feeling of pleasure and reward. RLS is thought to be caused by a combination of genetic and environmental
Restless Legs Syndrome Treatment Market Opportunities and Forecast Upto 2024
Global Restless Legs Syndrome Treatment Market: Overview Restless legs syndrome, also called Willis-Ekbom disease, is a neurological disorder. It triggers an urge in patients to move their legs. Because the syndrome usually occurs during sleep, it is also considered a type of sleep disorder. People suffering from restless legs syndrome often feel an overwhelming desire to rigorously move their legs, the intensity and frequency of which leads to unpleasant pain in
Restless Legs Syndrome - Pipeline Review And Market Research Report 2017
A latest research report titled as ”Restless Legs Syndrome - Pipeline Review And Market Research Report 2017” has been recently added to the vast portfolio of Market Research Hub (MRH) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an exhaustive enquiry with
Restless Legs Syndrome – Pipeline Share, Trends and Research Report (2017)
Albany, New York, March 15, 2017: Market Research Hub has recently announced the report on “Restless Legs Syndrome”. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome Pipeline Review, H1 2017, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Request a Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1021063 Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder of the part of the
Restless Legs Syndrome - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Pulmonary Restless Legs Syndrome - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome - Pipeline Review, H1 2017, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder
Global Restless Legs Syndrome Consumption 2016 Market Research Report
ReportBazzar has announced a new report titled "Global Restless Legs Syndrome Consumption 2016 Market Research Report" To their offerings Browse Report Summary with TOC: http://www.reportbazzar.com/product/global-restless-legs-syndrome-consumption-2016-market-research-report/ The Global Restless Legs Syndrome Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Restless Legs Syndrome market. First, the report provides a basic overview of the Restless Legs Syndrome industry including definitions, classifications, applications and industry chain structure. And